Literature DB >> 15533450

Hetero-assembly between all-L- and all-D-amino acid transmembrane domains: forces involved and implication for inactivation of membrane proteins.

Neta Sal-Man1, Doron Gerber, Yechiel Shai.   

Abstract

Protein-protein interactions within the membrane, partially or fully mediated by transmembrane (TM) domains, are involved in many vital cellular processes. Since the unique feature of the membrane environment enables protein-protein assembly that otherwise is not energetically favored in solution, the structural restrictions involved in the assembly of soluble proteins are not necessarily valid for the assembly of TM domains. Here we used the N-terminal TM domain (Tar-1) of the Escherichia coli aspartate receptor as a model system for examining the stereospecificity of TM-TM interactions in vitro and in vivo in isolated systems, and in the context of the full receptor. For this propose, we synthesized Tar-1 all-l and all-d amino acid TM peptides, a mutant TM peptide and an unrelated TM peptide. The data revealed: (i) Tar-1 all-d specifically associated with Tar-1 all-l within a model lipid membrane, as determined by using fluorescence energy transfer experiments; (ii) Tar-1 all-l and all-d, but not the control peptides, demonstrated a dose-dependant dominant negative effect on the Tar-1 TM homodimerization in the bacterial ToxR assembly system, suggesting a wild-type-like interaction; and most interestingly, (iii) both Tar-1 all-l and all-d showed a remarkable ability to inhibit the chemotaxis response of the full-length receptor, in vivo. Peptide binding to the bacteria was confirmed through confocal imaging, and Western blotting confirmed that ToxR Tar-1 chimera protein levels are not affected by the presence of the exogenous peptides. These findings present the first evidence that an all-d TM domain peptide acts in vivo similarly to its parental all-l peptide and suggest that the dimerization of the TM domains is mainly mediated by side-chain interactions, rather than geometrically fitted conformations. In addition, the study provides a new approach for modifying the function of membrane proteins by proteolysis-free peptides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533450     DOI: 10.1016/j.jmb.2004.09.066

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

Review 1.  Single-spanning transmembrane domains in cell growth and cell-cell interactions: More than meets the eye?

Authors:  Pierre Hubert; Paul Sawma; Jean-Pierre Duneau; Jonathan Khao; Jérôme Hénin; Dominique Bagnard; James Sturgis
Journal:  Cell Adh Migr       Date:  2010-04-20       Impact factor: 3.405

2.  High-resolution structures of a heterochiral coiled coil.

Authors:  David E Mortenson; Jay D Steinkruger; Dale F Kreitler; Dominic V Perroni; Gregory P Sorenson; Lijun Huang; Ritesh Mittal; Hyun Gi Yun; Benjamin R Travis; Mahesh K Mahanthappa; Katrina T Forest; Samuel H Gellman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

3.  Role of chirality in peptide-induced formation of cholesterol-rich domains.

Authors:  Richard M Epand; Scott D Rychnovsky; Jitendra D Belani; Raquel F Epand
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

4.  Transmembrane region of bacterial chemoreceptor is capable of promoting protein clustering.

Authors:  Abiola M Pollard; Victor Sourjik
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

5.  Transmembrane domain oligomerization propensity determined by ToxR assay.

Authors:  Catherine Joce; Alyssa Wiener; Hang Yin
Journal:  J Vis Exp       Date:  2011-05-26       Impact factor: 1.355

6.  An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action.

Authors:  Omri Faingold; Avraham Ashkenazi; Nathali Kaushansky; Avraham Ben-Nun; Yechiel Shai
Journal:  J Biol Chem       Date:  2013-09-27       Impact factor: 5.157

7.  Multi-Tox: application of the ToxR-transcriptional reporter assay to the study of multi-pass protein transmembrane domain oligomerization.

Authors:  Catherine Joce; Alyssa A Wiener; Hang Yin
Journal:  Biochim Biophys Acta       Date:  2011-07-23

Review 8.  Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptides.

Authors:  Avraham Ashkenazi; Yechiel Shai
Journal:  Eur Biophys J       Date:  2011-01-22       Impact factor: 1.733

9.  Drug efflux by a small multidrug resistance protein is inhibited by a transmembrane peptide.

Authors:  Bradley E Poulsen; Charles M Deber
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

10.  The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner.

Authors:  Linda Tomasinsig; Cinzia Pizzirani; Barbara Skerlavaj; Patrizia Pellegatti; Sara Gulinelli; Alessandro Tossi; Francesco Di Virgilio; Margherita Zanetti
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.